share_log

新銳醫藥:股東特別大會通告

NEW RAY MEDIC: NOTICE OF SPECIAL GENERAL MEETING

Hong Kong Stock Exchange ·  Jun 21 20:42
Summary by Futu AI
新銳醫藥國際控股有限公司將於2024年7月16日舉行股東特別大會,以審議及投票通過一項普通決議案。該決議案涉及本公司間接全資附屬公司Major Bright Holdings Limited與于文勇先生於2024年5月16日簽訂的買賣協議,該協議為收購事項。大會將授權董事會或其委員會進行必要行動,以完成收購事項及相關交易。股東將於2024年7月11日至16日間無法進行股份過戶登記,以確定出席大會及投票的資格。最後過戶登記日期為2024年7月10日。新銳醫藥主席、行政總裁兼執行董事王秋勤於2024年6月21日發出通告。
新銳醫藥國際控股有限公司將於2024年7月16日舉行股東特別大會,以審議及投票通過一項普通決議案。該決議案涉及本公司間接全資附屬公司Major Bright Holdings Limited與于文勇先生於2024年5月16日簽訂的買賣協議,該協議為收購事項。大會將授權董事會或其委員會進行必要行動,以完成收購事項及相關交易。股東將於2024年7月11日至16日間無法進行股份過戶登記,以確定出席大會及投票的資格。最後過戶登記日期為2024年7月10日。新銳醫藥主席、行政總裁兼執行董事王秋勤於2024年6月21日發出通告。
New Ray Medic International Holdings Limited will hold a special shareholders' meeting on July 16, 2024 to consider and vote on a ordinary resolution. The resolution relates to a purchase agreement signed on May 16, 2024 between the company's wholly-owned subsidiary, Major Bright Holdings Limited, and Mr. Yu Wen Yong, for an acquisition. The meeting will authorize the board of directors or its committee to take necessary actions to complete the acquisition and related transactions. Shareholders will not be able to transfer shares between July 11 and 16, 2024 to determine eligibility to attend and vote at the meeting. The final registration date is July 10, 2024. The Chairman, CEO and Executive Director of New Ray Medic, Wang Qiuqin, issued the notice on June 21, 2024.
New Ray Medic International Holdings Limited will hold a special shareholders' meeting on July 16, 2024 to consider and vote on a ordinary resolution. The resolution relates to a purchase agreement signed on May 16, 2024 between the company's wholly-owned subsidiary, Major Bright Holdings Limited, and Mr. Yu Wen Yong, for an acquisition. The meeting will authorize the board of directors or its committee to take necessary actions to complete the acquisition and related transactions. Shareholders will not be able to transfer shares between July 11 and 16, 2024 to determine eligibility to attend and vote at the meeting. The final registration date is July 10, 2024. The Chairman, CEO and Executive Director of New Ray Medic, Wang Qiuqin, issued the notice on June 21, 2024.

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.